This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Delli-Bovi, P Articles by Basilico, C Search for Related Content PubMed PubMed Citation Articles by Delli-Bovi, P Articles by Basilico, C

 Previous Article  |  Next Article 

Mol Cell Biol. 1988 July; 8(7): 2933-2941

Processing, secretion, and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potential.

P Delli-Bovi, A M Curatola, K M Newman, Y Sato, D Moscatelli, R M Hewick, D B Rifkin and C Basilico

Department of Pathology, New York University School of Medicine, New York 10016.

ABSTRACT

We recently reported that the protein encoded in a novel human oncogene isolated from Kaposi sarcoma DNA was a growth factor with significant homology to basic and acidic fibroblast growth factors (FGFs). To study the properties of this growth factor (referred to as K-FGF) and the mechanism by which the K-fgf oncogene transforms cells, we have studied the production and processing of K-FGF in COS-1 cells transfected with a plasmid encoding the K-fgf cDNA. The results show that, unlike basic and acidic FGFs, the K-FGF protein is cleaved after a signal peptide, glycosylated, and efficiently secreted as a mature protein of 176 or 175 amino acids. Inhibition of glycosylation impaired secretion, and the stability of the secreted K-FGF was greatly enhanced by the presence of heparin in the cultured medium. We have used the conditioned medium from transfected COS-1 cells to test K-FGF biological activity. Similar to basic FGF, the K-FGF protein was mitogenic for fibroblasts and endothelial cells and induced the growth of NIH 3T3 mouse cells in serum-free medium. Accordingly, K-fgf-transformed NIH 3T3 cells grew in serum-free medium, consistent with an autocrine mechanism of growth. We have also expressed the protein encoded in the K-fgf protooncogene in COS-1 cells, and it was indistinguishable in its molecular weight, glycosylation, secretion, and biological activity from K-FGF. Taken together, these results suggest that the mechanism of activation of this oncogene is due to overexpression rather than to mutations in the coding sequences.

---

Mol Cell Biol. 1988 July; 8(7): 2933-2941

This article has been cited by other articles:

• Dolle, J.-P., Rezvan, A., Allen, F. D., Lazarovici, P., Lelkes, P. I. (2005). Nerve Growth Factor-Induced Migration of Endothelial Cells. J. Pharmacol. Exp. Ther. 315: 1220-1227 [Abstract] [Full Text]  
• Mishra, S., Raz, A., Murphy, L. J. (2004). Insulin-Like Growth Factor Binding Protein-3 Interacts with Autocrine Motility Factor/Phosphoglucose Isomerase (AMF/PGI) and Inhibits the AMF/PGI Function. Cancer Res. 64: 2516-2522 [Abstract] [Full Text]  
• Ishikawa, H., Heaney, A. P., Yu, R., Horwitz, G. A., Melmed, S. (2001). Human Pituitary Tumor-Transforming Gene Induces Angiogenesis. J. Clin. Endocrinol. Metab. 86: 867-874 [Abstract] [Full Text]  
• Croce, K., Flaumenhaft, R., Rivers, M., Furie, B., Furie, B. C., Herman, I. M., Potter, D. A. (1999). Inhibition of Calpain Blocks Platelet Secretion, Aggregation, and Spreading. J. Biol. Chem. 274: 36321-36327 [Abstract] [Full Text]  
• Lingen, M.W. (1999). Angiogenesis in the Development of Head and Neck Cancer and Its Inhibition By Chemopreventive Agents. CROBM 10: 153-164 [Abstract] [Full Text]  
• Feldman, B, Poueymirou, W, Papaioannou, V., DeChiara, T., Goldfarb, M (1995). Requirement of FGF-4 for postimplantation mouse development. Science 267: 246-249 [Abstract]  
• Frenz, D., Liu, W, Williams, J., Hatcher, V, Galinovic-Schwartz, V, Flanders, K., Van de Water, T. (1994). Induction of chondrogenesis: requirement for synergistic interaction of basic fibroblast growth factor and transforming growth factor-beta. Development 120: 415-424 [Abstract]  
• Graves, D. T., Cochran, D. L. (1990). Mesenchymal Cell Growth Factors. CROBM 1: 17-36 [Full Text]  
• Allen, B. L., Filla, M. S., Rapraeger, A. C. (2001). Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition. JCB 155: 845-858 [Abstract] [Full Text]